首页> 外文期刊>Analytical and Bioanalytical Chemistry >Molecularly imprinted monolith in-tube solid-phase microextraction coupled with HPLC/UV detection for determination of 8-hydroxy-2′-deoxyguanosine in urine
【24h】

Molecularly imprinted monolith in-tube solid-phase microextraction coupled with HPLC/UV detection for determination of 8-hydroxy-2′-deoxyguanosine in urine

机译:分子印迹整体式管内固相微萃取与HPLC / UV检测联用测定尿液中的8-羟基-2'-脱氧鸟苷

获取原文
获取原文并翻译 | 示例
       

摘要

Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) has been widely used as a biomarker of oxidative DNA damage. Measurements of 8-OHdG in urinary samples are challenging owing to the low level of 8-OHdG and the complex matrix. In this study, a novel molecularly imprinted polymer (MIP) monolithic column was synthesized with guanosine as a dummy template which was used as the medium for in-tube solid-phase microextraction (SPME). In-tube SPME coupled with HPLC/UV detection for extraction and determination of urinary 8-OHdG was developed. The synthesized MIP monolithic column exhibited high extraction efficiency owing to its greater phase ratio with convective mass transfer and inherent selectivity. The enrichment factor for 8-OHdG was found to be 76 and the limits of detection and quantification of the method for urinary samples were 3.2 nmol/L (signal-to-noise ratio 3) and 11 nmol/L (signal-to-noise ratio 10), respectively. The MIP’s selectivity also made the sample preparation procedure and chromatographic separation much easier. The linear range of the proposed method was from 0.010 to 5.30 μmol/L (r = 0.9997), with a relative standard deviation of 1.1–6.8%, and the recovery for spiked urine samples was 84 ± 3%. The newly developed method was successfully applied to determine urinary samples of healthy volunteers, coking plant workers, and cancer patients. The 8-OHdG level in cancer patients was significantly higher than that in healthy people.
机译:尿液中的8-hydroxy-2'-deoxyguanosine(8-OHdG)已被广泛用作氧化性DNA损伤的生物标记。由于8-OHdG和复杂基质的含量较低,因此尿液样品中8-OHdG的测量具有挑战性。在这项研究中,合成了一种新型的分子印迹聚合物(MIP)整体柱,其中鸟嘌呤为虚拟模板,用作管内固相微萃取(SPME)的介质。开发了管内SPME结合HPLC / UV检测技术来提取和测定尿中的8-OHdG。合成的MIP整体柱由于具有较高的相比,对流传质和固有的选择性,因此具有较高的萃取效率。发现8-OHdG的富集因子为76,尿液样品检测和定量方法的极限为3.2 nmol / L(信噪比3)和11 nmol / L(信噪比)比率10)。 MIP的选择性也使样品制备过程和色谱分离变得更加容易。该方法的线性范围为0.010至5.30μmol/ L(r = 0.9997),相对标准偏差为1.1–6.8%,加标尿液样品的回收率为84±3%。新开发的方法已成功用于确定健康志愿者,炼焦厂工人和癌症患者的尿液样本。癌症患者的8-OHdG水平显着高于健康人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号